
IVITF
Healthcare · Drug Manufacturers - Specialty & Generic · $4.5M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Dec 29, 2019 | After the close | — | -0.04 | — |
| Sep 27, 2019 | Before the open | — | -0.05 | — |
| May 29, 2019 | After the close | — | -0.03 | — |
| Apr 30, 2019 | Time not confirmed | — | -0.03 | — |
| Dec 20, 2018 | Before the open | — | -0.09 | — |
| Sep 28, 2018 | After the close | — | -0.08 | — |
| May 29, 2018 | Before the open | — | -0.03 | — |
| Apr 30, 2018 | Time not confirmed | — | -0.04 | — |
Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada. The company operates through two segments, Sale of Cannabis and Fertilizers. It produces and sells medical cannabis; and plant fertilizers, nutrients, and other supplies for hydroponics, as well as operates medical clinics in Alberta. The company was incorporated in 2014 and is headquartered in…